The optimal timing and duration of daily G-CSF for primary prophylaxis after adjuvant TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy in breast cancer patients. (March 2019) - Kim, Z.; Lee, J.E.; Lee, J.; Hur, S.M.; Han, S.W.; Kim, S.Y.; Lim, C.W.